EP4216905A1 - Kosmetische zusammensetzung mit wechselnder textur in form einer wasser-in-öl-emulsion - Google Patents
Kosmetische zusammensetzung mit wechselnder textur in form einer wasser-in-öl-emulsionInfo
- Publication number
- EP4216905A1 EP4216905A1 EP21791433.2A EP21791433A EP4216905A1 EP 4216905 A1 EP4216905 A1 EP 4216905A1 EP 21791433 A EP21791433 A EP 21791433A EP 4216905 A1 EP4216905 A1 EP 4216905A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- weight
- fatty
- starch
- composition
- natural
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 114
- 239000002537 cosmetic Substances 0.000 title claims abstract description 41
- 239000007762 w/o emulsion Substances 0.000 title claims abstract description 16
- -1 alkyl glucoside Chemical class 0.000 claims abstract description 112
- 150000002191 fatty alcohols Chemical class 0.000 claims abstract description 48
- 229920002125 Sokalan® Polymers 0.000 claims abstract description 36
- 229920006395 saturated elastomer Polymers 0.000 claims abstract description 32
- 150000001875 compounds Chemical class 0.000 claims abstract description 25
- 229930182478 glucoside Natural products 0.000 claims abstract description 25
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 24
- 229930195729 fatty acid Natural products 0.000 claims abstract description 24
- 239000000194 fatty acid Substances 0.000 claims abstract description 24
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims abstract description 23
- 229920001296 polysiloxane Polymers 0.000 claims abstract description 21
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 claims abstract description 19
- 229910019142 PO4 Inorganic materials 0.000 claims abstract description 19
- 239000010452 phosphate Substances 0.000 claims abstract description 19
- 229960001631 carbomer Drugs 0.000 claims abstract description 18
- 230000001804 emulsifying effect Effects 0.000 claims abstract description 18
- 239000000843 powder Substances 0.000 claims abstract description 17
- 229940086555 cyclomethicone Drugs 0.000 claims abstract description 16
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims abstract description 15
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims abstract description 15
- 238000009472 formulation Methods 0.000 claims abstract description 15
- 229960005323 phenoxyethanol Drugs 0.000 claims abstract description 15
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims abstract description 15
- 239000012874 anionic emulsifier Substances 0.000 claims abstract description 14
- 239000003599 detergent Substances 0.000 claims abstract description 14
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000003349 gelling agent Substances 0.000 claims abstract description 13
- 125000003118 aryl group Chemical group 0.000 claims abstract description 10
- 229920002472 Starch Polymers 0.000 claims description 28
- 235000019698 starch Nutrition 0.000 claims description 23
- 239000008107 starch Substances 0.000 claims description 23
- 235000013311 vegetables Nutrition 0.000 claims description 17
- ATVJXMYDOSMEPO-UHFFFAOYSA-N 3-prop-2-enoxyprop-1-ene Chemical compound C=CCOCC=C ATVJXMYDOSMEPO-UHFFFAOYSA-N 0.000 claims description 13
- 239000004141 Sodium laurylsulphate Substances 0.000 claims description 12
- 229910052783 alkali metal Inorganic materials 0.000 claims description 11
- 240000003183 Manihot esculenta Species 0.000 claims description 10
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 claims description 10
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 claims description 8
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 7
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 7
- 229930006000 Sucrose Natural products 0.000 claims description 7
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 claims description 7
- 239000005720 sucrose Substances 0.000 claims description 7
- 229920000881 Modified starch Polymers 0.000 claims description 6
- 125000000217 alkyl group Chemical group 0.000 claims description 6
- 229920001519 homopolymer Polymers 0.000 claims description 6
- 235000019426 modified starch Nutrition 0.000 claims description 6
- 229920002261 Corn starch Polymers 0.000 claims description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical group OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 5
- 240000004713 Pisum sativum Species 0.000 claims description 5
- 235000011684 Sorghum saccharatum Nutrition 0.000 claims description 5
- 239000008120 corn starch Substances 0.000 claims description 5
- 239000003995 emulsifying agent Substances 0.000 claims description 5
- 150000008131 glucosides Chemical class 0.000 claims description 5
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims description 5
- 229920001592 potato starch Polymers 0.000 claims description 5
- 229940100486 rice starch Drugs 0.000 claims description 5
- 229940100445 wheat starch Drugs 0.000 claims description 5
- 229940081733 cetearyl alcohol Drugs 0.000 claims description 4
- ZUVCYFMOHFTGDM-UHFFFAOYSA-N hexadecyl dihydrogen phosphate Chemical compound CCCCCCCCCCCCCCCCOP(O)(O)=O ZUVCYFMOHFTGDM-UHFFFAOYSA-N 0.000 claims description 4
- 125000000129 anionic group Chemical group 0.000 claims description 3
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 claims description 3
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 claims description 3
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 claims description 2
- 240000006394 Sorghum bicolor Species 0.000 claims 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 1
- 239000000839 emulsion Substances 0.000 description 65
- 239000003921 oil Substances 0.000 description 34
- 235000019198 oils Nutrition 0.000 description 34
- 210000003491 skin Anatomy 0.000 description 28
- 239000012071 phase Substances 0.000 description 26
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 18
- 238000000034 method Methods 0.000 description 15
- 239000000047 product Substances 0.000 description 15
- 239000000284 extract Substances 0.000 description 14
- 241000196324 Embryophyta Species 0.000 description 12
- 239000008346 aqueous phase Substances 0.000 description 12
- 239000004480 active ingredient Substances 0.000 description 11
- 239000003795 chemical substances by application Substances 0.000 description 11
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 10
- 150000004665 fatty acids Chemical class 0.000 description 10
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 10
- 239000004615 ingredient Substances 0.000 description 9
- 239000012875 nonionic emulsifier Substances 0.000 description 9
- 230000001953 sensory effect Effects 0.000 description 9
- 235000002639 sodium chloride Nutrition 0.000 description 9
- 239000004094 surface-active agent Substances 0.000 description 9
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 8
- 150000002148 esters Chemical class 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 230000009471 action Effects 0.000 description 7
- 239000013543 active substance Substances 0.000 description 7
- 150000001720 carbohydrates Chemical class 0.000 description 7
- 125000004432 carbon atom Chemical group C* 0.000 description 7
- 235000012907 honey Nutrition 0.000 description 7
- 229930195733 hydrocarbon Natural products 0.000 description 7
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 6
- 239000004215 Carbon black (E152) Substances 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 235000019864 coconut oil Nutrition 0.000 description 6
- 239000003240 coconut oil Substances 0.000 description 6
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- 150000002430 hydrocarbons Chemical class 0.000 description 6
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 6
- 229960002446 octanoic acid Drugs 0.000 description 6
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- 230000003712 anti-aging effect Effects 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000000419 plant extract Substances 0.000 description 5
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- YWWVWXASSLXJHU-AATRIKPKSA-N (9E)-tetradecenoic acid Chemical compound CCCC\C=C\CCCCCCCC(O)=O YWWVWXASSLXJHU-AATRIKPKSA-N 0.000 description 4
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 4
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 4
- GHVNFZFCNZKVNT-UHFFFAOYSA-M decanoate Chemical compound CCCCCCCCCC([O-])=O GHVNFZFCNZKVNT-UHFFFAOYSA-M 0.000 description 4
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 4
- ZQPPMHVWECSIRJ-MDZDMXLPSA-N elaidic acid Chemical compound CCCCCCCC\C=C\CCCCCCCC(O)=O ZQPPMHVWECSIRJ-MDZDMXLPSA-N 0.000 description 4
- 230000007717 exclusion Effects 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 210000004209 hair Anatomy 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 4
- 230000003020 moisturizing effect Effects 0.000 description 4
- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 description 4
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 4
- 239000002304 perfume Substances 0.000 description 4
- 239000000546 pharmaceutical excipient Substances 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 230000000007 visual effect Effects 0.000 description 4
- 239000001993 wax Substances 0.000 description 4
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 3
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 3
- 102000011782 Keratins Human genes 0.000 description 3
- 108010076876 Keratins Proteins 0.000 description 3
- 235000021319 Palmitoleic acid Nutrition 0.000 description 3
- 235000010582 Pisum sativum Nutrition 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 240000003829 Sorghum propinquum Species 0.000 description 3
- 235000021355 Stearic acid Nutrition 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 3
- DDJSWKLBKSLAAZ-UHFFFAOYSA-N cyclotetrasiloxane Chemical compound O1[SiH2]O[SiH2]O[SiH2]O[SiH2]1 DDJSWKLBKSLAAZ-UHFFFAOYSA-N 0.000 description 3
- 229940008099 dimethicone Drugs 0.000 description 3
- 239000004205 dimethyl polysiloxane Substances 0.000 description 3
- 150000002170 ethers Chemical class 0.000 description 3
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 150000004804 polysaccharides Chemical class 0.000 description 3
- 229920002545 silicone oil Polymers 0.000 description 3
- 239000000344 soap Substances 0.000 description 3
- 238000003892 spreading Methods 0.000 description 3
- 230000007480 spreading Effects 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 150000003626 triacylglycerols Chemical class 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- NRTKYSGFUISGRQ-UHFFFAOYSA-N (3-heptanoyloxy-2,2-dimethylpropyl) heptanoate Chemical compound CCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCC NRTKYSGFUISGRQ-UHFFFAOYSA-N 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- OVYMWJFNQQOJBU-UHFFFAOYSA-N 1-octanoyloxypropan-2-yl octanoate Chemical compound CCCCCCCC(=O)OCC(C)OC(=O)CCCCCCC OVYMWJFNQQOJBU-UHFFFAOYSA-N 0.000 description 2
- ABEXEQSGABRUHS-UHFFFAOYSA-N 16-methylheptadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C ABEXEQSGABRUHS-UHFFFAOYSA-N 0.000 description 2
- GLCFQKXOQDQJFZ-UHFFFAOYSA-N 2-ethylhexyl 12-hydroxyoctadecanoate Chemical compound CCCCCCC(O)CCCCCCCCCCC(=O)OCC(CC)CCCC GLCFQKXOQDQJFZ-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- PIFPCDRPHCQLSJ-WYIJOVFWSA-N 4,8,12,15,19-Docosapentaenoic acid Chemical compound CC\C=C\CC\C=C\C\C=C\CC\C=C\CC\C=C\CCC(O)=O PIFPCDRPHCQLSJ-WYIJOVFWSA-N 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- YWWVWXASSLXJHU-UHFFFAOYSA-N 9E-tetradecenoic acid Natural products CCCCC=CCCCCCCCC(O)=O YWWVWXASSLXJHU-UHFFFAOYSA-N 0.000 description 2
- 244000144725 Amygdalus communis Species 0.000 description 2
- 235000011437 Amygdalus communis Nutrition 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- PIFPCDRPHCQLSJ-UHFFFAOYSA-N Clupanodonic acid Natural products CCC=CCCC=CCC=CCCC=CCCC=CCCC(O)=O PIFPCDRPHCQLSJ-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 244000020551 Helianthus annuus Species 0.000 description 2
- 235000003222 Helianthus annuus Nutrition 0.000 description 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 239000005639 Lauric acid Substances 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- 108010038807 Oligopeptides Proteins 0.000 description 2
- 102000015636 Oligopeptides Human genes 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- UWHZIFQPPBDJPM-FPLPWBNLSA-M Vaccenic acid Natural products CCCCCC\C=C/CCCCCCCCCC([O-])=O UWHZIFQPPBDJPM-FPLPWBNLSA-M 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 235000020224 almond Nutrition 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 229940114079 arachidonic acid Drugs 0.000 description 2
- 235000021342 arachidonic acid Nutrition 0.000 description 2
- 229960001948 caffeine Drugs 0.000 description 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 239000008406 cosmetic ingredient Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- HOBAELRKJCKHQD-QNEBEIHSSA-N dihomo-γ-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O HOBAELRKJCKHQD-QNEBEIHSSA-N 0.000 description 2
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 2
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 2
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid group Chemical group C(CCCCCC)(=O)O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 229940060384 isostearyl isostearate Drugs 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000002366 lipolytic effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000035800 maturation Effects 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 239000012764 mineral filler Substances 0.000 description 2
- 210000004400 mucous membrane Anatomy 0.000 description 2
- 235000021290 n-3 DPA Nutrition 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920005862 polyol Polymers 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- NNNVXFKZMRGJPM-KHPPLWFESA-N sapienic acid Chemical compound CCCCCCCCC\C=C/CCCCC(O)=O NNNVXFKZMRGJPM-KHPPLWFESA-N 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 2
- UWHZIFQPPBDJPM-BQYQJAHWSA-N trans-vaccenic acid Chemical compound CCCCCC\C=C\CCCCCCCCCC(O)=O UWHZIFQPPBDJPM-BQYQJAHWSA-N 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- VMPHSYLJUKZBJJ-UHFFFAOYSA-N trilaurin Chemical compound CCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC)COC(=O)CCCCCCCCCCC VMPHSYLJUKZBJJ-UHFFFAOYSA-N 0.000 description 2
- 229910052721 tungsten Inorganic materials 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- OUZJJDFOKSDCHY-UHFFFAOYSA-N 14-methylpentadecyl 12-octadecanoyloxyoctadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(CCCCCC)CCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C OUZJJDFOKSDCHY-UHFFFAOYSA-N 0.000 description 1
- LGEZTMRIZWCDLW-UHFFFAOYSA-N 14-methylpentadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C LGEZTMRIZWCDLW-UHFFFAOYSA-N 0.000 description 1
- RWKSBJVOQGKDFZ-UHFFFAOYSA-N 16-methylheptadecyl 2-hydroxypropanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)C(C)O RWKSBJVOQGKDFZ-UHFFFAOYSA-N 0.000 description 1
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 description 1
- ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 2,3-dimethylbutane Chemical group CC(C)C(C)C ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 0.000 description 1
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 1
- FWIUBOWVXREPPL-UHFFFAOYSA-N 2-[2-(7-methyloctanoyloxy)ethoxy]ethyl 7-methyloctanoate Chemical compound CC(C)CCCCCC(=O)OCCOCCOC(=O)CCCCCC(C)C FWIUBOWVXREPPL-UHFFFAOYSA-N 0.000 description 1
- NFIHXTUNNGIYRF-UHFFFAOYSA-N 2-decanoyloxypropyl decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)OC(=O)CCCCCCCCC NFIHXTUNNGIYRF-UHFFFAOYSA-N 0.000 description 1
- OPJWPPVYCOPDCM-UHFFFAOYSA-N 2-ethylhexyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC OPJWPPVYCOPDCM-UHFFFAOYSA-N 0.000 description 1
- XMFXBMLFOSSELI-UHFFFAOYSA-N 2-octyldodecyl 12-octadecanoyloxyoctadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(CCCCCC)CCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC XMFXBMLFOSSELI-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- PBWGCNFJKNQDGV-UHFFFAOYSA-N 6-phenylimidazo[2,1-b][1,3]thiazol-5-amine Chemical compound N1=C2SC=CN2C(N)=C1C1=CC=CC=C1 PBWGCNFJKNQDGV-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 244000061520 Angelica archangelica Species 0.000 description 1
- 241000242757 Anthozoa Species 0.000 description 1
- 235000000832 Ayote Nutrition 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 235000007689 Borago officinalis Nutrition 0.000 description 1
- 240000004355 Borago officinalis Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 235000016401 Camelina Nutrition 0.000 description 1
- 244000197813 Camelina sativa Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 235000014653 Carica parviflora Nutrition 0.000 description 1
- 235000014036 Castanea Nutrition 0.000 description 1
- 241001070941 Castanea Species 0.000 description 1
- 240000006162 Chenopodium quinoa Species 0.000 description 1
- 235000005633 Chrysanthemum balsamita Nutrition 0.000 description 1
- 244000260524 Chrysanthemum balsamita Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241001491621 Corallina officinalis Species 0.000 description 1
- 235000002787 Coriandrum sativum Nutrition 0.000 description 1
- 244000018436 Coriandrum sativum Species 0.000 description 1
- 240000009226 Corylus americana Species 0.000 description 1
- 235000001543 Corylus americana Nutrition 0.000 description 1
- 235000007466 Corylus avellana Nutrition 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 240000004244 Cucurbita moschata Species 0.000 description 1
- 235000009854 Cucurbita moschata Nutrition 0.000 description 1
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 108010016626 Dipeptides Proteins 0.000 description 1
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 description 1
- 239000004266 EU approved firming agent Substances 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 235000010099 Fagus sylvatica Nutrition 0.000 description 1
- 240000000731 Fagus sylvatica Species 0.000 description 1
- 235000016622 Filipendula ulmaria Nutrition 0.000 description 1
- 244000061544 Filipendula vulgaris Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 240000001238 Gaultheria procumbens Species 0.000 description 1
- 235000007297 Gaultheria procumbens Nutrition 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 235000018625 Helichrysum angustifolium Nutrition 0.000 description 1
- 244000000182 Helichrysum angustifolium Species 0.000 description 1
- 241001088392 Helichrysum formosissimum Species 0.000 description 1
- 235000013530 Helichrysum italicum Nutrition 0.000 description 1
- 235000005206 Hibiscus Nutrition 0.000 description 1
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 description 1
- 244000284380 Hibiscus rosa sinensis Species 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- 241000245713 Kniphofia Species 0.000 description 1
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 241000234435 Lilium Species 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 235000010649 Lupinus albus Nutrition 0.000 description 1
- 240000000894 Lupinus albus Species 0.000 description 1
- 241000208467 Macadamia Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 244000070406 Malus silvestris Species 0.000 description 1
- 241000736304 Marsilea Species 0.000 description 1
- 240000005125 Myrtus communis Species 0.000 description 1
- 235000013418 Myrtus communis Nutrition 0.000 description 1
- HEUQYIQQCNOXOG-UHFFFAOYSA-N N-undecanoylglycine Chemical compound CCCCCCCCCCC(=O)NCC(O)=O HEUQYIQQCNOXOG-UHFFFAOYSA-N 0.000 description 1
- 241000234479 Narcissus Species 0.000 description 1
- 241000219925 Oenothera Species 0.000 description 1
- 235000004496 Oenothera biennis Nutrition 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- OQILCOQZDHPEAZ-UHFFFAOYSA-N Palmitinsaeure-octylester Natural products CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 1
- 240000004370 Pastinaca sativa Species 0.000 description 1
- 235000017769 Pastinaca sativa subsp sativa Nutrition 0.000 description 1
- 244000025272 Persea americana Species 0.000 description 1
- 235000008673 Persea americana Nutrition 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241001092489 Potentilla Species 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 240000001890 Ribes hudsonianum Species 0.000 description 1
- 235000016954 Ribes hudsonianum Nutrition 0.000 description 1
- 235000001466 Ribes nigrum Nutrition 0.000 description 1
- 235000004443 Ricinus communis Nutrition 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 240000007651 Rubus glaucus Species 0.000 description 1
- 235000011034 Rubus glaucus Nutrition 0.000 description 1
- 235000009122 Rubus idaeus Nutrition 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 240000000513 Santalum album Species 0.000 description 1
- 235000008632 Santalum album Nutrition 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000040738 Sesamum orientale Species 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 206010040904 Skin odour abnormal Diseases 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- LPGFSDGXTDNTCB-UHFFFAOYSA-N [3-(16-methylheptadecanoyloxy)-2,2-bis(16-methylheptadecanoyloxymethyl)propyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCC(C)C)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C LPGFSDGXTDNTCB-UHFFFAOYSA-N 0.000 description 1
- SMLXTTLNOGQHHB-UHFFFAOYSA-N [3-docosanoyloxy-2,2-bis(docosanoyloxymethyl)propyl] docosanoate Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCCCC)(COC(=O)CCCCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCCCCCC SMLXTTLNOGQHHB-UHFFFAOYSA-N 0.000 description 1
- OBNDGIHQAIXEAO-UHFFFAOYSA-N [O].[Si] Chemical group [O].[Si] OBNDGIHQAIXEAO-UHFFFAOYSA-N 0.000 description 1
- 239000002535 acidifier Substances 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 125000000746 allylic group Chemical group 0.000 description 1
- 235000020194 almond milk Nutrition 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 125000004103 aminoalkyl group Chemical group 0.000 description 1
- 230000003656 anti-hair-loss Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002225 anti-radical effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 238000009341 apiculture Methods 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- 229920000617 arabinoxylan Polymers 0.000 description 1
- 150000004783 arabinoxylans Chemical class 0.000 description 1
- 229940067599 ascorbyl glucoside Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940090958 behenyl behenate Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 210000001736 capillary Anatomy 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 230000010267 cellular communication Effects 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- 229940048851 cetyl ricinoleate Drugs 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000004581 coalescence Methods 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 229940071160 cocoate Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000007799 cork Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 125000005534 decanoate group Chemical class 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 229940096810 diethylhexyl sebacate Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 229940120503 dihydroxyacetone Drugs 0.000 description 1
- VJHINFRRDQUWOJ-UHFFFAOYSA-N dioctyl sebacate Chemical compound CCCCC(CC)COC(=O)CCCCCCCCC(=O)OCC(CC)CCCC VJHINFRRDQUWOJ-UHFFFAOYSA-N 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 231100000507 endocrine disrupting Toxicity 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UQPHVQVXLPRNCX-UHFFFAOYSA-N erythrulose Chemical compound OCC(O)C(=O)CO UQPHVQVXLPRNCX-UHFFFAOYSA-N 0.000 description 1
- FMMOOAYVCKXGMF-MURFETPASA-N ethyl linoleate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OCC FMMOOAYVCKXGMF-MURFETPASA-N 0.000 description 1
- 229940031016 ethyl linoleate Drugs 0.000 description 1
- GJQLBGWSDGMZKM-UHFFFAOYSA-N ethylhexyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(CC)CCCCC GJQLBGWSDGMZKM-UHFFFAOYSA-N 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 210000000720 eyelash Anatomy 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000002343 gold Chemical class 0.000 description 1
- 229940087559 grape seed Drugs 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 231100000042 hematotoxic Toxicity 0.000 description 1
- 230000002012 hematotoxic effect Effects 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- 231100000334 hepatotoxic Toxicity 0.000 description 1
- 230000003082 hepatotoxic effect Effects 0.000 description 1
- 239000008131 herbal destillate Substances 0.000 description 1
- 239000008241 heterogeneous mixture Substances 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- XAMHKORMKJIEFW-AYTKPMRMSA-N hexadecyl (z,12r)-12-hydroxyoctadec-9-enoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC\C=C/C[C@H](O)CCCCCC XAMHKORMKJIEFW-AYTKPMRMSA-N 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 239000003752 hydrotrope Substances 0.000 description 1
- 150000001261 hydroxy acids Chemical class 0.000 description 1
- YODZNEIDVLFIIC-UHFFFAOYSA-N icosan-10-yl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(CCCCCCCCC)CCCCCCCCCC YODZNEIDVLFIIC-UHFFFAOYSA-N 0.000 description 1
- LTYSCLBTUYRCBF-UHFFFAOYSA-N icosan-9-yl 2-hydroxyoctadecanoate Chemical compound CCCCCCCCCCCCCCCCC(O)C(=O)OC(CCCCCCCC)CCCCCCCCCCC LTYSCLBTUYRCBF-UHFFFAOYSA-N 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 102000006495 integrins Human genes 0.000 description 1
- 108010044426 integrins Proteins 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 229940078545 isocetyl stearate Drugs 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 150000002515 isoflavone derivatives Chemical class 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 229940100554 isononyl isononanoate Drugs 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940075495 isopropyl palmitate Drugs 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- FMMOOAYVCKXGMF-UHFFFAOYSA-N linoleic acid ethyl ester Natural products CCCCCC=CCC=CCCCCCCCC(=O)OCC FMMOOAYVCKXGMF-UHFFFAOYSA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229940078752 magnesium ascorbyl phosphate Drugs 0.000 description 1
- 150000002696 manganese Chemical class 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000006083 mineral thickener Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 230000003227 neuromodulating effect Effects 0.000 description 1
- 150000002814 niacins Chemical class 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- VNLRTFSQCPNNIM-UHFFFAOYSA-N octadecyl octanoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCCCCCC VNLRTFSQCPNNIM-UHFFFAOYSA-N 0.000 description 1
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical class C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 1
- AFBUJPLSNNUUBE-UHFFFAOYSA-N octan-4-yl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(CCC)CCCC AFBUJPLSNNUUBE-UHFFFAOYSA-N 0.000 description 1
- 125000005474 octanoate group Chemical class 0.000 description 1
- 125000005473 octanoic acid group Chemical class 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 229940124531 pharmaceutical excipient Drugs 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229940057874 phenyl trimethicone Drugs 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229940043707 polyglyceryl-6 distearate Drugs 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- RMGVATURDVPNOZ-UHFFFAOYSA-M potassium;hexadecyl hydrogen phosphate Chemical compound [K+].CCCCCCCCCCCCCCCCOP(O)([O-])=O RMGVATURDVPNOZ-UHFFFAOYSA-M 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 235000015136 pumpkin Nutrition 0.000 description 1
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- 229920005573 silicon-containing polymer Polymers 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- ABTZKZVAJTXGNN-UHFFFAOYSA-N stearyl heptanoate Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)CCCCCC ABTZKZVAJTXGNN-UHFFFAOYSA-N 0.000 description 1
- 229940098758 stearyl heptanoate Drugs 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 229940098385 triisostearin Drugs 0.000 description 1
- HTJNEBVCZXHBNJ-XCTPRCOBSA-H trimagnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;diphosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O HTJNEBVCZXHBNJ-XCTPRCOBSA-H 0.000 description 1
- LINXHFKHZLOLEI-UHFFFAOYSA-N trimethyl-[phenyl-bis(trimethylsilyloxy)silyl]oxysilane Chemical compound C[Si](C)(C)O[Si](O[Si](C)(C)C)(O[Si](C)(C)C)C1=CC=CC=C1 LINXHFKHZLOLEI-UHFFFAOYSA-N 0.000 description 1
- COXJMKGEQAWXNP-UHFFFAOYSA-N tris(14-methylpentadecyl) 2-hydroxypropane-1,2,3-tricarboxylate Chemical compound CC(C)CCCCCCCCCCCCCOC(=O)CC(O)(C(=O)OCCCCCCCCCCCCCC(C)C)CC(=O)OCCCCCCCCCCCCCC(C)C COXJMKGEQAWXNP-UHFFFAOYSA-N 0.000 description 1
- ZQTYRTSKQFQYPQ-UHFFFAOYSA-N trisiloxane Chemical compound [SiH3]O[SiH2]O[SiH3] ZQTYRTSKQFQYPQ-UHFFFAOYSA-N 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- DTOSIQBPPRVQHS-UHFFFAOYSA-N α-Linolenic acid Chemical compound CCC=CCC=CCC=CCCCCCCCC(O)=O DTOSIQBPPRVQHS-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/064—Water-in-oil emulsions, e.g. Water-in-silicone emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/342—Alcohols having more than seven atoms in an unbroken chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/604—Alkylpolyglycosides; Derivatives thereof, e.g. esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Definitions
- Cosmetic composition with evolving texture in the form of a water-in-oil emulsion Cosmetic composition with evolving texture in the form of a water-in-oil emulsion
- the present invention relates to cosmetic body care compositions in the form of a water-in-oil (W/O) emulsion with an evolving texture and advantageous sensory properties, free of certain undesirable compounds often presented as essential in the formulation of products cosmetics.
- W/O water-in-oil
- Cosmetic body care compositions are widely used on a daily basis.
- the texture and sensory properties are important criteria for their commercial success. Indeed, the final consumer's choice is based both on technical performance criteria and on sensory criteria and immediate well-being provided by the cosmetic formulations applied to the skin.
- the exclusion of controversial ingredients for the preparation of cosmetic formulations is also an element of the commercial success of these products because it responds to a growing concern of consumers: their health.
- sulphated detergents such as sodium lauryl sulphate, essentially used as a surfactant, which is a well-known irritant, and which is moreover frequently used to experimentally induce contact dermatitis
- aromatic glycol ethers such as phenoxyethanol, a preservative considered harmful in particular for pregnant women and young children, as it is considered hematotoxic and hepatotoxic
- silicone compounds such as cyclomethicone, which is partly made up of cyclopentasiloxane and cyclotetrasiloxane, which have shown endocrine disrupting effects. Cyclotetrasiloxane in particular is classified as toxic to reproduction. Highly volatile, the silicone compounds provide a non-greasy feel and promote the spreading of the product on the skin.
- sulphated detergents such as sodium lauryl sulphate, a powerful surfactant
- sulphated detergents such as sodium lauryl sulphate
- surfactants are essential.
- An emulsion is a macroscopically homogeneous but microscopically heterogeneous mixture of an oily (or lipophilic) phase and an aqueous (or hydrophilic) phase that are immiscible liquids, such as water and an oil.
- An oily (or lipophilic) phase and an aqueous (or hydrophilic) phase that are immiscible liquids, such as water and an oil.
- One phase is dispersed in the second phase as droplets.
- the water is dispersed in the oil.
- the choice of the surfactant system becomes delicate since it directly influences the stability of the emulsion. Substitution of one surfactant by another can cause instability of the emulsion appearing during its conservation.
- This stability problem can induce a drop in viscosity, and/or a very coarse microscopic appearance with the presence of oil in the aqueous phase, or conversely a presence of water in the oily phase, which is obviously not desired. .
- the sulfated detergent(s) are replaced by other surfactants, in addition to the stability aspect, the sensoriality and/or the texture may be modified. The same is true for the substitution of silicone compounds such as cyclomethicone and aromatic glycol ethers such as phenoxyethanol, which modifies the sensoriality and/or the texture of the composition.
- one of the major challenges is to introduce high-performance biological active ingredients into emulsions while providing (or keeping ) a good level of sensoriality and enjoyment cosmetics in order to encourage the use of these products and thus intensify their observed effects on the skin through regular and repeated use.
- these active ingredients can be used at high rates, but can however pose sensory problems such as the provision of a sticky and/or rough effect on the skin during the treatment phase. application and/or after penetration of the product into the skin.
- another challenge for the formulator of skin care products is to offer pleasant and adequate textures in terms of sensoriality for the consumer target.
- compositions for caring for the skin in the form of an emulsion enriched with active molecules; stable; bringing a double evolutionary property in texture and sensoriality; and free from the so-called "soaping" phenomenon.
- cosmetic compositions free of silicone compound such as cyclomethicone, sulphated detergent such as sodium lauryl sulphate, and aromatic glycol ether such as phenoxyethanol, while making it possible to maintain/obtain the texture and sensoriality targets sought by consumers without posing problems of discomfort, sensory pleasure or stability.
- the aim of the invention is to solve the technical problem consisting in providing a composition, in particular a cosmetic composition, in the form of a stable emulsion, with an evolving structure, and free from the so-called “soaping” phenomenon.
- the present invention also aims to provide such a composition without altering the sensory aspect perceived by the user.
- the present invention also aims to provide such a composition without resorting to silicone compounds such as cyclomethicone, sulphated detergents such as sodium lauryl sulphate, and aromatic glycol ethers such as phenoxyethanol, controversial ingredients which are become undesirable in the formulation of cosmetic compositions.
- silicone compounds such as cyclomethicone, sulphated detergents such as sodium lauryl sulphate, and aromatic glycol ethers such as phenoxyethanol, controversial ingredients which are become undesirable in the formulation of cosmetic compositions.
- Another object of the present invention is to identify one or more substances making it possible to formulate a composition with an evolving texture in the form of a water-in-oil emulsion, without negatively affecting the sensoriality of the final composition.
- an anionic fatty alkyl phosphate emulsifier preferably an alkali metal salt of fatty alkyl phosphate
- a feel powder preferably chosen from natural or modified starches, preferably of natural origin
- the applicant has in fact found, surprisingly, that it is possible to obtain a composition fulfilling all of the desired criteria (containing active molecules, stable, providing a dual property that evolves in texture and sensoriality, which does not soap, and free from silicone compound such as cyclomethicone, sulphated detergent such as sodium lauryl sulphate, and aromatic glycol ether such as phenoxyethanol), using an emulsion containing the combination of components (i) to (v) mentioned above -above.
- silicone compound such as cyclomethicone, sulphated detergent such as sodium lauryl sulphate, and aromatic glycol ether such as phenoxyethanol
- the first subject of the present invention is a cosmetic composition with an evolving texture in the form of a water-in-oil emulsion comprising, in a physiologically acceptable medium:
- At least one anionic fatty alkyl phosphate emulsifier preferably an alkali metal salt of fatty alkyl phosphate
- esterified oil preferably of vegetable origin based on a C8-C10 fatty acid ester of C12-18 saturated fatty alcohol, preferably a caprylic/capric acid ester of C12-18 saturated fatty alcohol; said composition being free of silicone compound such as cyclomethicone, sulphated detergent such as sodium lauryl sulphate, and aromatic glycol ether such as phenoxyethanol.
- fatty acid is understood to mean an aliphatic chain carboxylic acid with a carbon chain of 4 to 22 carbon atoms.
- family of fatty acids mention may be made, for example, of caprylic acid, capric acid, lauric acid, myristic acid, palmitic acid, stearic acid, arachidic acid, dodecanoic acid, myristoleic acid, palmitoleic acid, sapienic acid, oleic acid, elaidic acid, trans-vaccenic acid, linoleic acid, linolelaic acid, ⁇ -linolenic acid , y-linolenic acid, dihomo-y-linolenic acid, arachidonic acid, eicosapentaenoic acid, and clupanodonic acid.
- fatty alcohol means an alcohol comprising a linear or branched carbon chain, saturated or unsaturated corresponding to a fatty acid carbon chain known to those skilled in the art. It can be a carbon chain obtained from a fatty acid such as caprylic acid, capric acid, caproic acid, lauric acid, myristic acid, palmitic acid, palmitoleic acid, stearic acid, arachidic acid, dodecanoic acid, myristoleic acid, palmitoleic acid, stearic acid, arachidic acid, sapienic acid, oleic acid, elaidic acid, trans-vaccenic acid, linoleic acid, I inolelaidic acid, a-linolenic acid, y-linolenic acid, dihomo-y-linolenic acid, arachidonic acid , eicosapentaenoic acid, or clupanodonic acid.
- a fatty acid such as caprylic acid, cap
- fatty alkyl means a linear or branched, saturated or unsaturated carbon chain corresponding to a fatty acid carbon chain known to those skilled in the art, as defined above.
- Cx-Cy acid and “Cx-Cy alcohol” means an acid and an alcohol, respectively, comprising a linear or branched aliphatic carbon chain which may comprise x to y carbon atoms, for example from 1 to 22 carbon atoms.
- Cx-Cy alkyl means a linear or branched aliphatic carbon chain which may comprise from x to y carbon atoms.
- compositions of the invention are intended for topical application to the skin, they comprise a physiologically acceptable medium, that is to say a medium compatible with all keratin materials such as the skin, the nails, the mucous membranes and the keratin fibers (such as hair, eyelashes), preferably skin.
- the nonionic emulsifying system can have an HLB of 10.
- the nonionic emulsifying system can advantageously comprise a C12 to C22 fatty alkyl glucoside, preferably from C16 to C18, and a C12 to C22 fatty alcohol, from preferably from C16 to C18.
- the C12 to C22 fatty alkyl glucoside, and the C12 to C22 fatty alcohol may be present in a fatty alkyl glucoside/fatty alcohol ratio of 10/90 to 30/70, for example from 15/85 to 25/65, preferably 20/80.
- the glucoside can be a D-glucopyranoside.
- the nonionic emulsifying system can comprise a mixture of cetearyl D-glucopyranoside and cetearyl alcohol, preferably in the aforementioned ratios. It may be, for example, a 20/80 cetearyl glucoside/cetearyl alcohol mixture. It is possible to use, for example, Emulgade PL 68/50TM marketed by the company BASF.
- an anionic emulsifier based on fatty alkyl phosphate preferably an alkali metal salt of fatty alkyl phosphate, as described previously and below (for example a salt potassium fatty alkyl phosphate C14 to C18) it allows the development of W / O emulsions according to the present invention.
- the nonionic emulsifying system can be present at a rate of 1 to 5% by weight, preferably 2.0 to 3.0% by weight, preferably 2.2 to 2.8% by weight, relative to the weight composition total.
- the anionic emulsifier may comprise an alkali metal salt of C12 to C22 fatty alkyl phosphate, preferably C13 to C20, preferably C14 to C18. It may for example be an alkali metal salt of cetyl phosphate, preferably a potassium salt of cetyl phosphate.
- an alkali metal salt of cetyl phosphate preferably a potassium salt of cetyl phosphate.
- the anionic emulsifier can be present at a rate of 0.01 to 1% by weight, preferably 0.05 to 0.4% by weight, preferably 0.1 to 0.4% by weight, preferably 0.1 to 0.3% by weight, relative to the total weight of the composition.
- the gelling agent can comprise at least one carbomer compound.
- carbomer is understood to mean an optionally crosslinked homopolymer, resulting from the polymerization of acrylic acid. It is therefore an optionally crosslinked poly(acrylic acid).
- carbomers which can be used in the context of the invention, mention may be made of those sold under the names TegoOCarbomer 340FD from Evonik, Carbobopol® 981 from Lubrizol, Carbopol® ETD 2050 from Lubrizol, or else Carbopol® Iltrez 10 from Lubrizol.
- carrier also encompasses polymers of high molecular weight acrylic acid crosslinked with allylic sucrose or allylic ethers of pentaerythritol (handbook of Pharmaceutical Excipients, 5 th Edition, plll).
- it may be Carbopol®910, Carbopol®934, Carbopol®934P, Carbopol®940, Carbopol®941, Carbopol®71 G, Carbopol®980, Carbopol®971 P or Carbopol®974P from Lubrizol. Mention may also be made of Carbopol® Clear Polymer from Lubrizol.
- Carbomers have other names: polyacrylic acids, carboxyvinyl polymers or carboxy polyethylenes.
- the carbomer will advantageously be chosen from homopolymers of acrylic acid crosslinked with an allyl ether of pentaerythritol, an allyl ether of sucrose, or an allyl propylene ether.
- the carbomer marketed under the name Carbopol®940 by the company Lubrizol may be used.
- the carbomer gelling agent may be present at a rate of 0.05 to 1% by weight, preferably 0.20 to 0.40% by weight, preferably 0.28 to 0.35% by weight, relative to the weight composition total. touch powder
- touch powder means a powder of natural origin obtained from starch, providing slipperiness, matt softness and sensoriality. It is typically used in cosmetics for a powdery, slippery and soft finish without a greasy effect. It leaves a silky film on the skin.
- the touch powder can be chosen from corn starch, rice starch, tapioca starch, potato starch, wheat starch, sorghum starch, peas, natural or modified, preferably natural.
- the touch powder can advantageously be tapioca starch, natural or modified, preferably natural.
- the feel powder may be present in a proportion of 0.1 to 5% by weight, preferably 1 to 3% by weight relative to the total weight of the composition.
- the fatty phase of the W/O composition according to the invention can advantageously comprise at least one esterified oil, preferably of plant origin, based on a C8-C10 fatty acid ester of saturated C12 fatty alcohol. -18.
- It may be for example an esterified oil derived from coconut oil, comprising a mixture of a caprylic acid ester of saturated C12-18 fatty alcohol and a capric ester of fatty alcohol saturated with C12-18.
- the caprylate/caprate coconut oil marketed under the name Cetiol C5TM by the company BASF may be used.
- the esterified oil preferably of plant origin, based on a C8-C10 fatty acid ester of a saturated C12-18 fatty alcohol can be present in a proportion of 4 to 14% by weight, preferably 6 to 12% by weight, preferably 8 to 10% by weight relative to the total weight of the composition.
- oil we mean a substance composed of identical or different molecules having hydrophobic properties and liquid at room temperature.
- a nonionic emulsifying system of HLB > 9 based on fatty alkyl glucoside and fatty alcohol preferably in a mass ratio fatty alkyl/fatty alcohol glucoside ranging from 10/90 to 30/70, preferably from 15/85 to 25/75, preferably from 18/82 to 22/78, most preferably around 20/80, of an anionic emulsifier based on fatty alkyl phosphate, a gelling agent of the carbomer type, a feel powder, and an esterified oil, preferably of vegetable origin, based on a C8 fatty acid ester -C10 of C12-18 saturated fatty alcohol, as defined above, made it possible to obtain a composition in the form of a W/O emulsion fulfilling all the desired criteria (containing active molecules, stable, providing double property
- the term “evolving texture” is understood to mean a texture which develops over time.
- the texture of the final composition varies between the moment when the composition is prepared, and the moment when it reaches its peak of maturation (final texture).
- the texture of a cosmetic formulation can be characterized by its resistance to flow. It can be determined empirically, by visual observation of the flow of the cosmetic formulation under the effect of gravity and/or by measuring a maximum compression force implemented using a texturometer. equipped with a measurement probe and connected to data processing software.
- a composition will be said to be texture-changing if the texture (consistency) changes by > 5% by one of the aforementioned methods 30 days after its preparation.
- the combination of components (i) to (v) described above makes it possible to obtain a texture which evolves to a consistency similar to that of a flan.
- the term “stable” is understood to mean an emulsion which remains homogeneous on storage at room temperature (20 ⁇ 5° C.) after a minimum period of one month, independently of the evolution of its texture.
- the homogeneity of the composition can be evaluated by visual observation and/or by observation under a microscope of the composition spread on a slide.
- the emulsion will be considered stable if, when observed under a microscope, the size of the water droplets in the oily phase remains substantially homogeneous at room temperature for a minimum of one month. Conversely, a W/O emulsion will be considered as not fulfilling the stability criterion if, at the end of a storage period of at least one month at room temperature, no coalescence of the drops of water is observed. water leading to a very coarse microscopic appearance with the presence of water in the oily phase.
- the present invention relates to the use of the combination
- At least one fatty alkyl phosphate anionic emulsifier preferably an alkali metal salt of fatty alkyl phosphate
- At least one gelling agent of the carbomer type such as homopolymers of acrylic acid crosslinked with an allyl ether of pentaerythritol, an allyl ether of sucrose, or an allyl ether of propylene;
- At least one feel powder preferably chosen from natural or modified starches, preferably of natural origin, such as corn starch, rice starch, tapioca starch, potato starch, wheat starch, sorghum starch, pea starch, natural or modified, preferably natural, most preferably tapioca starch; and
- composition is a cosmetic composition, it contains a physiologically acceptable medium.
- physiologically acceptable medium in the present invention means a non-toxic medium, compatible with all keratin materials, in particular the skin.
- compositions according to the present invention naturally contain an aqueous phase and an oily phase.
- a cosmetically acceptable aqueous phase included in the compositions according to the invention which is in the form of a W/O emulsion contains water, and can conventionally contain one or more cosmetically acceptable organic solvents, a mixture of water and one or more cosmetically acceptable organic solvents.
- the cosmetically acceptable solvents can more particularly be chosen from polyhydric alcohols such as, for example, glycerol, diglycerol, glycerol oligomers, ethylene glycol, propylene glycol, butylene glycol, hexylene glycol, diethylene glycol, xylitol, erythritol, sorbitol, or water-soluble alcohols such as ethanol, isopropanol or butanol.
- aqueous phase of the composition according to the invention which is in the form of a W/O emulsion
- aqueous phase comprises water and any substance or preparation intended to be brought into contact with the superficial parts of the human body (epidermis, hair and capillary systems, nails, lips and external genitalia) or with the teeth and oral mucous membranes with a view, exclusively or mainly, to cleaning, perfume, modify their appearance, protect them, keep them in good condition and/or correct body odours.
- Oil phase The oily phase consists of oils and of all the other fatty substances and lipophilic constituents which may be present in the composition of the invention.
- the oily phase does not contain silicone oil, in order to meet the specifications for the exclusion of silicone compounds which are a source of controversy in cosmetics.
- component (v) is an esterified oil, it will form part of the oily phase.
- oil phase constituents examples include vegetable or non-vegetable oils, hydrocarbon oils, butters and waxes.
- hydrocarbon oil is understood to mean a non-silicone oil, that is to say any oil mainly comprising carbon and hydrogen atoms, and optionally ester, ether, fluorinated, carboxylic acid and/or alcohol groups.
- plant or “of plant origin”, is meant a substance extracted or derived from one or more parts of one or more plants. This therefore excludes in particular compounds derived from an animal.
- hydrocarbon oils which can be used in the composition of the invention, mention may be made of:
- hydrocarbon oils of animal origin such as perhydrosqualene and squalane
- hydrocarbon oils of vegetable origin such as liquid triglycerides of fatty acids comprising from 4 to 10 carbon atoms such as triglycerides of heptanoic or octanoic acids or, for example, sunflower, corn, soybean oils, pumpkin, grapeseed, sesame, hazelnut, apricot, macadamia, arara, sunflower, castor, avocado, triglycerides of caprylic/capric acids, such as coconut oil caprylate/caprate marketed under the name Cetiol C5TM such as those sold by BASF or those of the miglyol family, for example those sold under the names Miglyol 810, 812 and 818 by Dynamit Nobel, jojoba oil, shea butter oil;
- esters and ethers in particular of fatty acids, such as the oils of formulas R1COOR2 and R1OR2 in which Ri represents the remainder of a fatty acid containing from 8 to 29 carbon atoms, and R2 represents a hydrocarbon chain, branched or not, containing from 3 to 30 carbon atoms, such as for example Purcellin's oil, isopropyl myristate, ethyl-2-hexyl palmitate, octyl-2-dodecyl stearate, octyl-2-dodecyl erucate, isostearyl isostearate; hydroxylated esters such as isostearyl lactate, octylhydroxystearate, octyldodecyl hydroxystearate, diisostearyl malate, triisocetyl citrate, heptanoates, octanoates, decanoates of fatty alcohols;
- hydrocarbons of mineral or synthetic origin, such as paraffin oils, volatile or not, and their derivatives, petroleum jelly, polydecenes, hydrogenated polyisobutene such as Parleam oil.
- Component (v) may preferably be an esterified oil of vegetable origin, based on a C8-C10 fatty acid ester of C12-18 saturated fatty alcohol, preferably a caprylic acid ester/ capric saturated C12-18 fatty alcohol.
- component (v) may be caprylate/caprate coconut oil marketed under the name Cetiol C5TM by the company BASF.
- esterified oils preferably of vegetable origin (component (v)) based on a C8-C10 fatty acid ester of C12-18 saturated fatty alcohol, preferably a fatty acid ester caprylic/capric C12-18 saturated fatty alcohol are particularly preferred. It may be for example an esterified oil derived from coconut oil, comprising a mixture of a caprylic acid ester of saturated C12-18 fatty alcohol and a capric ester of fatty alcohol saturated with C12-18.
- the caprylate/caprate coconut oil marketed under the name Cetiol C5TM by the company BASF may be used.
- isononyl isononanoate is also part of the family of synthetic esters and ethers defined above. However, as mentioned previously, it is advantageously replaced by esterified oil (v) preferably of vegetable origin (natural origin), which makes it possible to obtain the target texture and sensoriality.
- esterified oil (v) preferably of vegetable origin (natural origin), which makes it possible to obtain the target texture and sensoriality.
- fatty substances of natural origin optionally present in the composition which is the subject of the present invention
- saturated or unsaturated, linear or branched fatty alcohols of plant origin saturated or unsaturated, linear or branched fatty acids of plant origin
- esters of fatty alcohols and saturated or unsaturated, linear or branched fatty acids of vegetable origin such as for example butyl stearate, cetyl palmitate, cetyl ricinoleate, decyl oleate, diisopropyl, diethylhexyl sebacate, ethyl linoleate, trilaurin
- isocetyl stearate isopropyl palmitate, isopropyl myristate, isostearyl isostearate, myristyl myristate, neopentylglycol diheptanoate , ethylhexyl cocoate, ethylhexyl hydroxyste
- compositions according to the present invention may typically comprise one or more topically acceptable adjuvants or excipients known to those skilled in the art (with the exception of silicone compound such as cyclomethicone, sulphated detergent such as sodium lauryl sulphate, and aromatic glycol ether such as phenoxyethanol), and optionally one or more active ingredients.
- topically acceptable adjuvants or excipients known to those skilled in the art (with the exception of silicone compound such as cyclomethicone, sulphated detergent such as sodium lauryl sulphate, and aromatic glycol ether such as phenoxyethanol), and optionally one or more active ingredients.
- topically acceptable adjuvants or excipients mention may be made, for example, of co-emulsifying surfactants, stabilizing agents, film-forming compounds, pearlescent agents, superfatting agents, thickening and/or gelling surfactants, sequestering agents, hydrotropes, plasticizers, mineral thickeners, organic thickeners, associative or not, perfumes, superfatting agents, alkanizing agents, acidifying agents, reducing agents, antioxidants, fatty substances of natural origin, preservatives, mineral fillers or pigments, particles providing a visual effect or intended for the encapsulation of active ingredients, exfoliating particles, texture agents, mineral fillers, dyes or any other topically acceptable adjuvant or excipient (with the exception of silicone compounds such as cyclomethicone, sulphated detergent such as sodium lauryl sulphate, and aromatic glycol ether such as phenoxyethanol, which can be cited in the INCI dictionary (International Nomenclature of Cosmetic Ingredients) published by the PCPC
- the cosmetic active agents mention may be made, for example, of the active principles having a moisturizing action, a tightening action, a soothing or relaxing action, an anti-inflammatory action, a slimming action, a lipolytic action, a draining action, a detoxifying action, a action an energizing, relaxing action, a stimulating action, an emollient action, a neuromodulating action, a protective action, a purifying, sebum-regulating, anti-hair loss action, an anti-aging action, a firming, restructuring, anti-radical or antioxidant action, or a mixture of at least two of these active ingredients.
- These active agents can be those commonly used in cosmetic and/or dermatological products.
- Such active principles are for example N-acylated proteins, N-acylated peptides such as for example MATRIXILTM, N-acylated amino acids present in their acid and/or salified forms such as for example N-(w- undecylenoyl) phenylalanine marketed by the company SEPPIC under the name SEPIWHITETMMSH, octanoylglycine marketed by the company SEPPIC under the name LIPACIDE TM C8G, undecylenoylglycine marketed by the company SEPPIC under the name LIPACIDE TM UG, hydrolysates N-acylated protein partials, amino acids, peptides, total protein hydrolysates, fat-soluble vitamins, fat-soluble vitamin derivatives such as for example Retinol, vitamin E and its derivatives, water-soluble and/or water-dispersible vitamins such as for example Vitamin C and its derivatives, magnesium ascorbyl phosphate and its derivatives, ascorbyl glucoside,
- anti-aging agents include, for example, oat extract, extracts obtained by biotechnology, for example hyaluronic acid, seaweed extracts, bioferments, bio-saccharide gum-1, saccharide gum-2, saccharide gum-3, saccharide gum-4, sugars, for example glucose, sucrose, fructose, honeys, flower nectars, fruit juices, polysaccharides , for example saccharide gum-1, saccharide gum-2, saccharide gum-3, saccharide gum-4, peptides, for example peptides resulting from an association of amino acids, or resulting from the cutting of proteins by biotechnology, for example dipeptides, tetrapeptides and/or oligopeptides.
- biotechnology for example hyaluronic acid, seaweed extracts, bioferments
- bio-saccharide gum-1, saccharide gum-2, saccharide gum-3, saccharide gum-4 sugars, for example glucose, sucrose, fructose, honeys, flower nectar
- moisturizing agents include for example glycerin, hyaluronic acid, polysaccharides, products from beekeeping, for example honey.
- soothing agents include, for example, bisabolol or allantoin.
- agents acting on the microcirculation include, for example, extracts of corallina officinalis.
- firming agents include for example a rye extract (rich in arabinoxylans), caffeine, tensor agents for example hibiscus oligopeptides, almond proteins. This or these agent(s) can be used in the composition of the present invention, for example at the concentrations usually used and known to those skilled in the art in cosmetic or dermatological compositions.
- the cosmetic active agents obtained from plants, such as a plant extract, an essential oil and/or any extract capable of being obtained from a plant material. It may for example be an extract obtained from all or part of a plant, for example flowers, stems, buds, fruits, roots, flowering tops, twigs, bark , radioles.
- It may be, for example, an everlasting flower extract (Helichrysum Italicum), angelica, almond, almond milk, cade, rosemary, sandalwood, chestnut, coriander, camelina, evening primrose, borage, apples, rice, meadowsweet, lemon, myrtle, water clover, sea lily, wintergreen, kniphofia, narcissus, white lupine, daisy, iris, pine, raspberry, blackcurrant, beech or any mixture thereof.
- flower extract Helichrysum Italicum
- angelica angelica
- almond almond milk
- cade rosemary
- sandalwood chestnut
- coriander camelina
- evening primrose borage
- apples rice, meadowsweet, lemon, myrtle, water clover, sea lily, wintergreen
- kniphofia narcissus
- white lupine daisy
- iris iris
- pine raspberry
- blackcurrant beech or any mixture thereof.
- cosmetic active agents mention may also be made, for example, of natural cosmetic active agents such as honey, for example acacia honey, thyme honey, orange blossom honey.
- the cosmetic compositions with an evolving texture in the form of a W/O emulsion according to the invention can be obtained by any suitable process known to those skilled in the art for the manufacture of a W/O emulsion, in particular in the cosmetics field.
- the method may include a step of mixing surfactants in water (eg, components (i) and (ii)). It may also be, for example, a process comprising a step of incorporating an internal phase into an external phase by means of an emulsifier, for example a turbine of the rotor-stator type.
- the process may comprise (a) preparation of a fatty phase, (b) preparation of an aqueous phase, (c) incorporation of the aqueous phase obtained in step (a) into the fatty phase obtained in step (b) with stirring to create an emulsion.
- Step (a) of preparing the fatty phase can be carried out by techniques well known to those skilled in the art, possibly with stirring while hot (for example between 40 and 85° C., for example between 50 and 70 °C).
- the agitation can be carried out by any suitable means, for example by a mixer with blades, or by any other system making it possible to meet the requirements of the mixture.
- Step (b) of preparing the aqueous phase can be carried out by techniques well known to those skilled in the art, and can be done in particular with stirring, optionally hot (for example between 45 and 65° C., for example between 50 and 60°C).
- the agitation can be carried out by a paddle mixer or by any other system making it possible to meet the requirements of the mixture (deflocculator, propeller, etc.).
- the tank in which the aqueous phase is prepared can contain a turbine and/or a scraper.
- Step (b) can be carried out in parallel with step (a) or prior to the latter.
- Step (c) of incorporating the aqueous phase into the fatty phase with vigorous stirring to manufacture an emulsion can be carried out by techniques well known to those skilled in the art.
- Step (c) can be carried out by any suitable means for obtaining an emulsion, for example by means of an emulsifier, or a turbine of the rotor-stator type.
- compositions according to the invention find their application in a large number of treatments, in particular cosmetic, of the skin, the lips and/or the hair, including the scalp, in particular for the protection and/or the care of the skin.
- the cosmetic compositions according to the invention can for example be used as a care product and for the face, the hands and/or the body with a consistency similar to that of flan, such as more or less unctuous creams.
- the invention also relates to a method (or process) for formulating a composition with a changing texture in the form of a water-in-oil emulsion, in particular free of silicone compound such as cyclomethicone, sulfated detergent such as sodium lauryl sulfate, and of aromatic glycol ether such as phenoxyethanol, said method comprising the addition to the emulsion (i) of at least one nonionic emulsifying system of HLB > 9, preferably of HLB > 10, based on glucoside d fatty alkyl and fatty alcohol, preferably in a fatty alkyl glucoside/fatty alcohol ratio by weight ranging from 10/90 to 30/70, preferably from 15/85 to 25/75, preferably from 18/82 to 22 /78, most preferably around 20/80;
- At least one fatty alkyl phosphate anionic emulsifier preferably an alkali metal salt of fatty alkyl phosphate
- At least one gelling agent of the carbomer type such as homopolymers of acrylic acid crosslinked with an allyl ether of pentaerythritol, an allyl ether of sucrose, or an allyl ether of propylene;
- At least one feel powder preferably chosen from natural or modified starches, preferably of natural origin, such as corn starch, rice starch, tapioca starch, potato starch, wheat starch, sorghum starch, pea starch, natural or modified, preferably natural, most preferably tapioca starch; and
- (v) at least one esterified oil preferably of vegetable origin based on a C8-C10 fatty acid ester of C12-18 saturated fatty alcohol, preferably a caprylic/capric acid ester of saturated C12-18 fatty alcohol, components (i) to (v) preferably being as previously defined.
- this method makes it possible in particular to preserve the sensoriality of the W/O emulsion, an evolving sensoriality: rich on application but which is absorbed quickly.
- Sensory means the appearance, smell, color and texture perceived and/or felt by the user when looking at, touching or applying the product on skin, lips, nails, and/or hair, preferably skin.
- retaining the sensoriality is meant the fact of not significantly modifying the sensoriality of the composition for the user, or even of retaining an identical sensoriality.
- a subject of the present invention is also a cosmetic care process for caring for the skin comprising a step of applying to the skin a cosmetic composition with an evolving texture in the form of a water-in-oil emulsion according to the invention.
- a cosmetic care process for caring for the skin comprising a step of applying to the skin a cosmetic composition with an evolving texture in the form of a water-in-oil emulsion according to the invention.
- the application to the skin can therefore be carried out depending on the galenic form used.
- the frequency of application can be any frequency desired by the user, for example daily, twice-daily, weekly and/or fortnightly application. This may be, for example, an application once a week, twice a week, three times a week or more, once a day, twice a day or more.
- the present invention has many advantages, in particular to make skincare compositions accessible in the form of a W/O emulsion: enriched with active molecules; which remain homogeneous on storage at room temperature after a minimum period of one month; bringing a double evolutionary property in texture and sensoriality; and free from the so-called “soaping" phenomenon.
- the present invention also has the advantage of providing compositions with an evolving texture for caring for the skin in the form of a W/O emulsion, which are free of silicone compound such as cyclomethicone, of sulfated detergent such as sodium lauryl sulfate, and aromatic glycol ether such as phenoxyethanol.
- silicone compound such as cyclomethicone
- sulfated detergent such as sodium lauryl sulfate
- aromatic glycol ether such as phenoxyethanol
- silicone compound any silicone compound known to those skilled in the art and/or capable of being used in a cosmetic, dermatological and/or pharmaceutical composition. It can be any inorganic compound formed of a silicon-oxygen chain (-Si-O-Si-O-Si-O-) on which groups are fixed, on the silicon atoms. It may also be any compound comprising the following 4 types of siloxane units: in which R can be an alkyl, for example a methyl, an aromatic radical, for example a phenyl group, an amine group, an aminoalkyl group, for example an aminodimethyl.
- R can be an alkyl, for example a methyl, an aromatic radical, for example a phenyl group, an amine group, an aminoalkyl group, for example an aminodimethyl.
- the cosmetic composition may be free of any silicone compound chosen from the group comprising dimethicones, cyclotetrasiloxane, cyclopentasiloxane, cyclomethicone, cyclohexasiloxane, cyclosiloxane, trisiloxane, dimethicone copolymer, vinyl dimethicone copolymer, polyglycoethylene 12 dimethicone, phenyltrimethicone, amodimethicone, cyclopentasiloxane, acrylates/polytrimethylsiloxymethacrylate copolymer.
- FIG. 1 represents a microscope photograph of (A) emulsion E 5 and (B) emulsion E4, respectively of Example 2, after spreading on a slide.
- FIG. 2 represents a photograph under the microscope (A) of the emulsion E 5, and (B) of the emulsion E4, respectively of Example 2, after spreading on a slide and testing the addition of a drop of water under the microscope slide to see the direction of the emulsion. The pictures show:
- Example 1 Example of cosmetic compositions with evolving texture in the form of a W/O emulsion according to the present invention
- Table 1 composition and ingredients of emulsions
- the emulsions thus prepared are then stored in an insulated climatic chamber regulated at a temperature of 20°C for 7 days. At the end of this period of 7 days, the appearance of each emulsion prepared is observed and the viscosity of each emulsion is measured at 25° C. using a Brookfield RV6 viscometer at 12 rpm.
- the emulsions are then replaced and stored in the same insulated climatic chamber, regulated at a temperature of 20°C for up to 1 month. After a period of one month, each emulsion left the enclosure climate to observe its appearance and measure its viscosity again at 25°C using a Brookfield RV6 viscometer at 12 rpm.
- compositions are W/O emulsions (confirmed under the microscope), and have the desired evolving texture: the viscosity at 25°C between D7 and D30 increases by around 25,000 cP (25 Pa.s) on D7 to reach 55,000 cP (55 Pa.s) at D30 (measured at 25° C., 12 rpm (“12 rpm” in English) with a Brookfield RV6 viscometer).
- a W/O emulsion (E4) prepared according to Example 1 is compared with the same emulsion (E5) in which the nonionic emulsifier of HLB > 10 based on fatty alkyl glucoside and fatty alcohol has been substituted. with another nonionic emulsifying system of HLB > 10, this time based on polyglyceryl-6 distearate.
- E4 emulsions contain the non-ionic emulsifier (ia), while E5 emulsions contain the non-ionic emulsifier (ib).
- the % ranges given for each ingredient denote the % ranges within which each ingredient can be used to prepare the emulsions according to the invention (E4), in comparison with the E5 emulsions not falling within the scope of the present invention.
- the principle of the table below is that the E4 and E5 emulsions contain the same percentage of each type of ingredient, so that they can be directly compared.
- an E4 emulsion according to the invention containing x1% by weight of nonionic emulsifier (ia), x2% by weight of anionic emulsifier (ii), x3% by weight of carbomer (iii), x4% by weight of starch of natural origin (iv), x5% by weight of caprylic/capric acid ester of saturated fatty alcohol C12-18 (v), x6% by weight of active ingredients, x7% by weight of perfume and x8% by weight of preservatives, will be compared with an E5 emulsion containing x1% by weight of nonionic emulsifier (ib), x2% by weight of anionic emulsifier (ii), x3% by weight of carbomer (iii), x4% by weight of starch of natural origin (iv), x5% by weight of caprylic/capric acid ester of saturated C12-18 fatty alcohol (v), x6% by weight of active ingredients, x7 % by weight of perfume
- Table 2 composition and ingredients of emulsions
- the emulsion obtained is O/W oriented (test of adding a drop of water under the microscope slide to see the direction of the emulsion - cf. FIG. 2A).
- the E4 emulsion is a W/O emulsion, which eliminates the soaping phenomenon (FIG. 2B). E4 also makes it possible to eliminate sodium lauryl sulphate, cyclomethicone and phenoxyethanol, like emulsions E1 to E3 of Example 1.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Dispersion Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR2009640A FR3114237B1 (fr) | 2020-09-23 | 2020-09-23 | Composition cosmétique à texture évolutive sous forme d’émulsion eau-dans-huile |
PCT/FR2021/051610 WO2022064130A1 (fr) | 2020-09-23 | 2021-09-21 | Composition cosmétique à texture évolutive sous forme d'émulsion eau-dans-huile |
Publications (1)
Publication Number | Publication Date |
---|---|
EP4216905A1 true EP4216905A1 (de) | 2023-08-02 |
Family
ID=74758856
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP21791433.2A Withdrawn EP4216905A1 (de) | 2020-09-23 | 2021-09-21 | Kosmetische zusammensetzung mit wechselnder textur in form einer wasser-in-öl-emulsion |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP4216905A1 (de) |
CN (1) | CN115989015A (de) |
FR (1) | FR3114237B1 (de) |
WO (1) | WO2022064130A1 (de) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2693466B1 (fr) | 1992-07-09 | 1994-09-16 | Oreal | Composition cosmétique sous forme d'émulsion triple eau/huile de silicone/eau gélifiée. |
FR2778858B1 (fr) | 1998-05-20 | 2000-06-16 | Oreal | Emulsion e/h/e stable et son utilisation comme composition cosmetique et/ou dermatologique |
FR2991877B1 (fr) * | 2012-06-19 | 2014-11-28 | Clarins Lab | Composition cosmetique comprenant un extrait de perichlaena richardii |
-
2020
- 2020-09-23 FR FR2009640A patent/FR3114237B1/fr active Active
-
2021
- 2021-09-21 CN CN202180053009.7A patent/CN115989015A/zh active Pending
- 2021-09-21 EP EP21791433.2A patent/EP4216905A1/de not_active Withdrawn
- 2021-09-21 WO PCT/FR2021/051610 patent/WO2022064130A1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
WO2022064130A1 (fr) | 2022-03-31 |
FR3114237A1 (fr) | 2022-03-25 |
FR3114237B1 (fr) | 2022-08-12 |
CN115989015A (zh) | 2023-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR3045338B1 (fr) | Composition comprenant au moins deux esters d'acide gras et de (poly)glycerol, et son utilisation en cosmetique | |
EP3554458B1 (de) | Verwendung einer kohlenwasserstoff-mischung zur verbesserung der sensorischen eigenschaften von glycerin enthaltenden öl-in-wasser-emulsionen | |
EP3554462A1 (de) | Verfahren zur verbesserung der sensorischen eigenschaften von öl-in-wasser-emulsionen | |
EP1027878A1 (de) | Kosmetische und/oder dermatologische Zusammensetzung in Form einer Emulsion gebildet aus Lipidvesikel die in einer wässrigen Phase mit mindestens einer aktiven Säure dispergiert ist | |
EP2459155A2 (de) | Öl-in-wasser-emulsion mit verbesserten sensorischen eigenschaften | |
FR2791566A1 (fr) | Composition contenant un actif instable en milieu oxydant, et ses utilisations notamment cosmetiques | |
FR3029781A1 (fr) | Composition comprenant de l'hesperetine, une huile, au moins un ester d'acide gras et de (poly)glycerol, un polyol | |
EP3174603A1 (de) | Camellia-japonica-extrakt und kosmetische zusammensetzungen davon | |
WO2021111065A1 (fr) | Composition cosmétique triphasique | |
FR3097433A1 (fr) | Composition comprenant au moins un copolymere d’amps®, au moins un acide acyl glutamique ou l’un de ses sels et au moins un alkylpolyglucoside | |
FR3020946A1 (fr) | Nouvelles preparations cosmetiques et/ou dermatologiques extemporanees | |
WO2022223933A1 (fr) | Composition cosmetique biphasique ecobiologique a separation de phases retardee | |
WO2017109192A2 (fr) | Composition a base d'acide spiculisporique | |
FR3021528A1 (fr) | Formulation cosmetique | |
FR3053587B1 (fr) | Composition notamment de type emulsion multiple et procede de preparation | |
EP4216905A1 (de) | Kosmetische zusammensetzung mit wechselnder textur in form einer wasser-in-öl-emulsion | |
EP0697207A1 (de) | Expandierte Polymer-Partikel enthältende Peelingzusammensetzung | |
FR3028750A1 (fr) | Composition cosmetique comprenant un phyllosilicate synthetique et un polyol | |
FR3075051B1 (fr) | Emulsion inverse comprenant de l’aerogel de silice, un alkylpolyglycoside, et un alcool gras dont la chaine grasse est differente de celle de l’alkylpolyglycoside | |
FR2949329A1 (fr) | Composition cosmetique comprenant un alcane lineaire volatil et un ester de sucrose | |
WO2023002123A1 (fr) | Composition cosmetique sous la forme d'emulsion huile-dans-eau a forte teneur en ingredients d'origine naturelle | |
FR3117345A1 (fr) | Composition pour le soin de la peau | |
FR3032611A1 (fr) | Utilisation de l'acide ellagique pour matifier la peau | |
WO2024110352A1 (fr) | Complexe hydratant, et utilisation dans des compositions hydratantes | |
WO2023217986A1 (fr) | Composition cosmetique solide anhydre comprenant le myristate de decaglycerol et une combinaison de corps gras |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20230223 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20240122 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20240523 |